Anti-Human CD3xCD19 Bispecific Antibody(Blinatumomab)

Size	Availability	Price(USD)	VIP Price (USD)	Quantity
1 mg	3-5days	$1500.00	Visible after login	- +
5 mg	3-5days	$4366.00	Visible after login	- +

Size

Availability

Price(USD)

VIP Price (USD)

Quantity

1 mg

3-5days

$1500.00

Visible after login

- +

5 mg

3-5days

$4366.00

Visible after login

- +

Product Overview

Product Name	Anti-Human CD3xCD19 Bispecific Antibody(Blinatumomab; Blincyto; MT103; MEDI-538; MEDI 538; Anti-human CD3 CD19; Human CD3 CD19 bispecific)
CAS	853426-35-4
Storage condition	Sealed and Store at -80°C. Aliquots should be stored at the same temperature after first use to avoid freeze-thaw cycles

Product details

Blinatumomab (Anatumomab) is a bispecific monoclonal antibody which can specifically targets the CD19 antigen present on B cells. Blinatumomab can be used for the research of acute lymphoblastic leukemia.

Related literature

The establishment and application of CD3E humanized mice in immunotherapy[J]

PMID: 35570001 PMCID: PMC9671771 DOI: 10.1538/expanim.22-0012

Blinatumomab versus Chemotherapy for Advanced Acute Lymphoblastic Leukemia.

PMID: 28249141 PMCID: PMC5881572 DOI: 10.1056/NEJMoa1609783

Blinatumomab, a Bi-Specific Anti-CD19/CD3 BiTE(®) Antibody for the Treatment of Acute Lymphoblastic Leukemia: Perspectives and Current Pediatric Applications.

PMID: 24744989 PMCID: PMC3978294 DOI: 10.3389/fonc.2014.00063

Sorry, no related items

History

CLA1082

Anti-Human CD3xCD19 Bispecific Antibody(Blinatumomab; Blincyto; MT103; MEDI-538; MEDI 538; Anti-human CD3 CD19; Human CD3 CD19 bispecific)

853426-35-4 95+%